Meniere's disease
LB Minor, DA Schessel, JP Carey - Current opinion in neurology, 2004 - journals.lww.com
LB Minor, DA Schessel, JP Carey
Current opinion in neurology, 2004•journals.lww.comVertigo is often the most debilitating symptom associated with Ménière's disease. Many
treatment options exist for the management of vertigo. Intratympanic injection of gentamicin
(low dose) can be used in patients for whom vertigo has not been controlled by medical
measures. Ongoing research is providing a greater understanding of the effects of
gentamicin on vestibular function and of the mechanisms through which gentamicin leads to
control of vertigo.
treatment options exist for the management of vertigo. Intratympanic injection of gentamicin
(low dose) can be used in patients for whom vertigo has not been controlled by medical
measures. Ongoing research is providing a greater understanding of the effects of
gentamicin on vestibular function and of the mechanisms through which gentamicin leads to
control of vertigo.
Summary
Vertigo is often the most debilitating symptom associated with Ménière's disease. Many treatment options exist for the management of vertigo. Intratympanic injection of gentamicin (low dose) can be used in patients for whom vertigo has not been controlled by medical measures. Ongoing research is providing a greater understanding of the effects of gentamicin on vestibular function and of the mechanisms through which gentamicin leads to control of vertigo.
Lippincott Williams & Wilkins